Charles Schwab
TFFP

Charles Schwab’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Charles Schwab’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-479
Closed -$49K – 3572
2022
Q3 		$49K Hold
479
– – ﹤0.01% 3334
2022
Q2 		$68K Hold
479
– – ﹤0.01% 3345
2022
Q1 		$76K Hold
479
– – ﹤0.01% 3462
2021
Q4 		$107K Hold
479
– – ﹤0.01% 3432
2021
Q3 		$93K Buy
+479
New +$102K ﹤0.01% 3387

Other funds holding TFFP

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab's TFFP Position: Q4 2022 in Review

Charles Schwab sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2022, closing a stake of 479 shares — an estimated $49K sold.

Charles Schwab first reported a position in TFFP in Q3 2021 and held it in 5 quarters. The position peaked at $107K in Q4 2021. 41 funds tracked by Wall St. Rank hold TFFP as of Q4 2022.

  • Charles Schwab reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Charles Schwab sold 479 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $49K.
  • Charles Schwab first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Charles Schwab's TFF Pharmaceuticals, Inc. Common Stock position peaked at $107K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.